1. Home
  2. CX vs NBIX Comparison

CX vs NBIX Comparison

Compare CX & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemex S.A.B. de C.V. Sponsored ADR

CX

Cemex S.A.B. de C.V. Sponsored ADR

HOLD

Current Price

$10.19

Market Cap

16.0B

Sector

Industrials

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$150.02

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CX
NBIX
Founded
1906
1992
Country
Mexico
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0B
15.5B
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
CX
NBIX
Price
$10.19
$150.02
Analyst Decision
Buy
Strong Buy
Analyst Count
8
22
Target Price
$12.21
$180.91
AVG Volume (30 Days)
5.0M
949.8K
Earning Date
04-23-2026
05-05-2026
Dividend Yield
0.74%
N/A
EPS Growth
N/A
41.95
EPS
N/A
3.30
Revenue
N/A
$161,626,000.00
Revenue This Year
$8.28
$24.73
Revenue Next Year
$4.34
$13.14
P/E Ratio
$19.03
$47.34
Revenue Growth
N/A
977.51
52 Week Low
$8.73
$122.14
52 Week High
$13.67
$186.12

Technical Indicators

Market Signals
Indicator
CX
NBIX
Relative Strength Index (RSI) 35.47 52.22
Support Level $10.46 $152.67
Resistance Level $13.30 $161.00
Average True Range (ATR) 0.23 4.14
MACD 0.02 0.85
Stochastic Oscillator 6.05 84.92

Price Performance

Historical Comparison
CX
NBIX

About CX Cemex S.A.B. de C.V. Sponsored ADR

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: